Black Friday saleUp to 70% OFF
666

BORA PHARMACEUTICALS CO LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

6472 chart


Full chart

6472 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪82.06 B‬ TWD
Dividend yield (indicated)
1.51%
Price to earnings Ratio (TTM)
21
Basic EPS (TTM)
38 TWD
Net income (FY)
‪3.03 B‬ TWD
Revenue (FY)
‪14.20 B‬ TWD
Shares float
‪62.24 M‬
Beta (1Y)
0.33

About BORA PHARMACEUTICALS CO LTD


Sector
Health Technology
CEO
Pao Hsi Sheng
Headquarters
Taipei
Website
bora-corp.com
Founded
2007
ISIN
TW0006472004
FIGI
BBG0076JFSF2
Bora Pharmaceuticals Co., Ltd. engages in the manufacturing and sales of generic, brand, and over-the-counter drugs. Its products include central nervous system medication, cardiovascular medicine, antibiotics, antivirals, ophthalmic, antipsychotics, dementia drugs, sleeping agents, lowering blood pressure drugs, and health food. The firm operates through the following segments: Sales, Manufacturing, and Other Segment. The Sales segment comprises of the pharmaceuticals and healthcare products. The Manufacturing segment consists of Contract development & manufacturing organization of pharmaceuticals. The Other Segment refers to the distributing and developing pharmaceuticals. Bora Pharmaceuticals was founded on June 12, 2007 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

6472 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6472 is 796 TWD — it has increased by 1.28% in the past 24 hours. Watch BORA PHARMACEUTICALS CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange BORA PHARMACEUTICALS CO LTD stocks are traded under the ticker 6472.
6472 stock has risen by 5.33% compared to the previous week, the month change is a 6.47% rise, over the last year BORA PHARMACEUTICALS CO LTD has showed a 16.54% increase.
We've gathered analysts' opinions on BORA PHARMACEUTICALS CO LTD future price: according to them, 6472 price has a max estimate of 1,025.00 TWD and a min estimate of 861.00 TWD. Watch 6472 chart and read a more detailed BORA PHARMACEUTICALS CO LTD stock forecast: see what analysts think of BORA PHARMACEUTICALS CO LTD and suggest that you do with its stocks.
6472 reached its all-time high on Jul 16, 2024 with the price of 975 TWD, and its all-time low was 612 TWD and was reached on Mar 11, 2024. View more price dynamics on 6472 chart.
See other stocks reaching their highest and lowest prices.
6472 stock is 1.89% volatile and has beta coefficient of 0.33. Track BORA PHARMACEUTICALS CO LTD stock price on the chart and check out the list of the most volatile stocks — is BORA PHARMACEUTICALS CO LTD there?
Today BORA PHARMACEUTICALS CO LTD has the market capitalization of ‪80.20 B‬, it has increased by 1.30% over the last week.
Yes, you can track BORA PHARMACEUTICALS CO LTD financials in yearly and quarterly reports right on TradingView.
BORA PHARMACEUTICALS CO LTD is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
6472 earnings for the last quarter are 14.15 TWD per share, whereas the estimation was 8.73 TWD resulting in a 62.08% surprise. The estimated earnings for the next quarter are 9.72 TWD per share. See more details about BORA PHARMACEUTICALS CO LTD earnings.
BORA PHARMACEUTICALS CO LTD revenue for the last quarter amounts to ‪5.62 B‬ TWD, despite the estimated figure of ‪5.27 B‬ TWD. In the next quarter, revenue is expected to reach ‪5.72 B‬ TWD.
6472 net income for the last quarter is ‪1.45 B‬ TWD, while the quarter before that showed ‪1.17 B‬ TWD of net income which accounts for 23.45% change. Track more BORA PHARMACEUTICALS CO LTD financial stats to get the full picture.
Yes, 6472 dividends are paid annually. The last dividend per share was 12.00 TWD. As of today, Dividend Yield (TTM)% is 1.54%. Tracking BORA PHARMACEUTICALS CO LTD dividends might help you take more informed decisions.
BORA PHARMACEUTICALS CO LTD dividend yield was 1.88% in 2023, and payout ratio reached 39.74%. The year before the numbers were 1.93% and 43.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BORA PHARMACEUTICALS CO LTD EBITDA is ‪4.87 B‬ TWD, and current EBITDA margin is 41.24%. See more stats in BORA PHARMACEUTICALS CO LTD financial statements.
Like other stocks, 6472 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BORA PHARMACEUTICALS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BORA PHARMACEUTICALS CO LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BORA PHARMACEUTICALS CO LTD stock shows the strong buy signal. See more of BORA PHARMACEUTICALS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.